[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.238.248.103. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
1.
Kwong  DL, Sham  JS, Chua  DT, Choy  DT, Au  GK, Wu  PM.  The effect of interruptions and prolonged treatment time in radiotherapy for nasopharyngeal carcinoma.   Int J Radiat Oncol Biol Phys. 1997;39(3):703-710. doi:10.1016/S0360-3016(97)00339-8PubMedGoogle ScholarCrossref
2.
Bleicher  RJ.  Timing and delays in breast cancer evaluation and treatment.   Ann Surg Oncol. 2018;25(10):2829-2838. doi:10.1245/s10434-018-6615-2PubMedGoogle ScholarCrossref
3.
Yu  J, Ouyang  W, Chua  MLK, Xie  C.  SARS-CoV-2 transmission in patients with cancer at a tertiary care hospital in Wuhan, China.   JAMA Oncol. Published online March 25, 2020. doi:10.1001/jamaoncol.2020.0980PubMedGoogle Scholar
4.
Li  Q, Guan  X, Wu  P,  et al.  Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia.   N Engl J Med. 2020;382(13):1199-1207. doi:10.1056/NEJMoa2001316PubMedGoogle ScholarCrossref
5.
Song  J-Y, Yun  J-G, Noh  J-Y, Cheong  H-J, Kim  W-J.  Covid-19 in South Korea: challenges of subclinical manifestations.   N Engl J Med. 2020;382(19):1858-1859. doi:10.1056/NEJMc2001801PubMedGoogle ScholarCrossref
6.
Pan  A, Liu  L, Wang  C,  et al.  Association of public health interventions with the epidemiology of the COVID-19 outbreak in Wuhan, China.   JAMA. 2020;323(19):1-9. doi:10.1001/jama.2020.6130PubMedGoogle ScholarCrossref
Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words
    Views 1,692
    Citations 0
    Research Letter
    July 30, 2020

    Outcomes in Radiotherapy-Treated Patients With Cancer During the COVID-19 Outbreak in Wuhan, China

    Author Affiliations
    • 1Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China
    • 2Hubei Key Laboratory of Tumor Biological Behaviors, Zhongnan Hospital of Wuhan University, Wuhan, China
    • 3Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan University, Wuhan, China
    • 4Division of Radiation Oncology, Division of Medical Sciences, National Cancer Centre Singapore, Singapore
    • 5Oncology Academic Clinical Programme, Duke–National University of Singapore Medical School, National University of Singapore, Singapore
    JAMA Oncol. Published online July 30, 2020. doi:10.1001/jamaoncol.2020.2783

    Several health care services have been affected by the novel coronavirus disease 2019 (COVID-19) pandemic. A delay in diagnosis and treatment can be detrimental to patients with cancer.1,2 However, patients with cancer are also at risk for COVID-19 because of immunosuppressive treatments and recurrent visits to the hospital.3 In this article, we report preliminary outcomes in 209 patients who underwent radiotherapy at the Zhongnan Hospital of Wuhan University (ZHWU) during the COVID-19 outbreak in the city of Wuhan, China.

    All patients who were treated at the Department of Medical and Radiation Oncology, ZHWU, from January 20 to March 5, 2020, were included. Public health measures implemented during the study period included city lockdown (January 23, 2020), cordon sanitaire, traffic restriction, social distancing, and home confinement. We analyzed patient demographics as well as clinical and treatment parameters. Survival status of all patients was updated as of March 12, 2020.

    ×